Impact of community pharmacist intervention discussing patients’ beliefs to improve medication adherence

International Journal of Clinical Pharmacy

Volumn 36, Issue 5, 2014, Pages 1048-1058

  Gujral, Gina ^a   Winckel, Karl ^a,b   Nissen, Lisa M ^a,c   Cottrell, W Neil ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Adherence; Australia; Beliefs; Community pharmacist intervention; Myocardial infarction; Repertory grid technique

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; FEMALE; HEALTH BELIEF; HEART INFARCTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; TEACHING HOSPITAL; TREATMENT REFUSAL; ATTITUDE TO HEALTH; MIDDLE AGED; PATIENT EDUCATION; PHARMACY; PROGRAM EVALUATION; PSYCHOLOGY;

COMMUNITY PHARMACY SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROGRAM EVALUATION;

EID: 84911437059     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-9993-y     Document Type: Article

References (39)

1. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Guidelines for the management of acute coronary syndromes. Med J Aust. 2006;184(8):1–32.
2. National Collaborating Centre For Primary Care. Secondary prevention in primary and secondary care for patients following a myocardial infarction. United Kingdom: National Institute for Health and Clinical Excellence; 2007.
3. Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2009;120(22):2271–306.
4. Chew DP, Aroney CN, Aylward PE, Kelly AM, White HD, Tideman PA, et al. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ. 2011;20(8):487–502.
5. Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006;6:48.
6. Choudhry NK, Glynn RJ, Avorn J, Lee JL, Brennan TA, Reisman L, et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014;167(1):51–8.e5.
7. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842–7.
8. Akincigil A, Bowblis JR, Levin C, Jan S, Patel M, Crystal S. Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction. J Gen Intern Med. 2008;23(2):115–21.
9. Sud A, Kline-Rogers EM, Eagle KA, Fang J, Armstrong DF, Rangarajan K, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39(11):1792–7.
10. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, 2003.
11. AlGhurair SA, Hughes CA, Simpson SH, Guirguis LM. A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens. 2012;14(12):877–86.
12. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
13. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1–47.
14. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.
15. Schwitzgebel E. “Belief”, The Stanford Encyclopedia of Philosophy 2014 [cited 2014 May 12]. Spring 2014 ed. http://plato.stanford.edu/entries/belief/.
16. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.
17. Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58(5):403–15.
18. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS ONE. 2013;8(12):e80633.
19. George J, Mackinnon A, Kong DC, Stewart K. Development and validation of the beliefs and behaviour questionnaire (BBQ). Patient Educ Couns. 2006;64(1–3):50–60.
20. McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25(1):215–38.
21. Hahn SR, Park J, Skinner EP, Yu-Isenberg KS, Weaver MB, Crawford B, et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008;24(7):2127–38.
22. Kelly GA. The psychology of personal constructs. 1st ed. New York: Norton; 1955.
23. Beller EM, Gebski V, Keech AC. Randomisation in clinical trials. Med J Aust. 2002;177(10):565–7.
24. Cottrell WN, Denaro CP, Emmerton L. Exploring beliefs about heart failure treatment in adherent and nonadherent patients: use of the repertory grid technique. Patient Prefer Adherence. 2013;7:141–50.
25. Percival M, Cottrell WN, Jayasinghe R. Exploring the beliefs of heart failure patients towards their heart failure medicines and self care activities. Int J Clin Pharm. 2012;34(4):618–25.
26. Mårdby AC, Åkerlind I, Jörgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69(1):158-164.
27. van den Bemt BJF, van den Hoogen FHJ, Benraad B, Hekster YA, van Riel PLCM, van Lankveld W. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009;36(10):2164–2170.
28. Geers HC, de Blaey CJ, Egberts AC, Bouvy ML, Heerdink ER. Early identification of long-term poor adherence in ambulatory patients. Ann Pharmacother. 2006;40(12):2277–8.
29. Hess G, Preblick R, Hill J, Plauschinat CA, Yaskin J. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure. Congest Heart Fail. 2009;15(4):170–5.
30. Perreault S, Dragomir A, Blais L, Berard A, Lalonde L, White M, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009;65(10):1013–24.
31. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43(3):413–22.
32. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177–86.
33. Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153–8.
34. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J. 2003;145(3):438–44.
35. Shah ND, Dunlay SM, Ting HH, Montori VM, Thomas RJ, Wagie AE, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122(10):961.e7–13.
36. Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, et al. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc. 2011;52(3):381–97.
37. Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LNM. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163(4):657–65.e1.
38. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108(1):20–7.
39. Rowe G, Lambert N, Bowling A, Ebrahim S, Wakeling I, Thomson R. Assessing patients’ preferences for treatments for angina using a modified repertory grid method. Soc Sci Med. 2005;60(11):2585–95.